Fairhaven Pharmaceuticals
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1917 W 4th Ave Ste 390, Vancouver, Briti...Revenue
$5.5 MillionIndustry
About Fairhaven Pharmaceuticals
Is Fairhaven Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Fairhaven Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Fairhaven Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Fairhaven Pharmaceuticals has new funding data
Product Launch: Get notified when Fairhaven Pharmaceuticals launches new products
Click to see if Fairhaven Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Fairhaven Pharmaceuticals recently announced quarterly report
Fairhaven Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Fairhaven Pharmaceuticals
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Fairhaven Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Fairhaven Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fairhaven Pharmaceuticals.
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Fairhaven Pharmaceuticals
Fairhaven Pharmaceuticals is a company that creates oral therapeutics to treat severe inflammatory conditions. The company provides a small molecule antagonist preclinical research program and other related services to develop oral therapeutics, allowing clinicians to treat patients with inflammatory conditions.... Read More